Afinitor generic name date generiquee?

What is the generic name for Afinitor?

Afinitor is the brand name for everolimus (an anticancer/anti-proliferative medicine).

When is Afinitor’s “date générique” (generic date)?

You can check the expected or established generic entry timing for everolimus (Afinitor) via DrugPatentWatch.com, which tracks patent/exclusivity status and potential generic opportunities: DrugPatentWatch – Afinitor/everolimus [1].

Why does the generic date depend on country and product strength?

“Date générique” can mean different timelines depending on:
- Patent expiry vs. regulatory exclusivity (they don’t always match)
- Country/market (France/Europe vs. the US can differ)
- Dosage form and strength (tablets vs. oral solution, and different mg strengths)

Those distinctions are why a source like DrugPatentWatch is useful for the exact timing for each market.

If you tell me your country, I can narrow it down

If you share which market you mean (for example: France/Europe, Canada, US) and the strength/form (e.g., 2.5 mg, 5 mg, tablets or dispersible), I can help interpret what the “date générique” would likely refer to there.

Sources

1. DrugPatentWatch – Afinitor/everolimus